RECRUITING

Digital Cognitive Behavioral Treatment of Insomnia in Youth: An RCT Examining Feasibility, Acceptability, and Efficacy of NiteCAPP Jr

Description

The proposed pilot will examine feasibility, acceptability, and preliminary efficacy of a digital CBT-I tailored for school-aged children.

Conditions

Study Overview

Study Details

Study overview

The proposed pilot will examine feasibility, acceptability, and preliminary efficacy of a digital CBT-I tailored for school-aged children.

Digital Cognitive Behavioral Treatment of Insomnia in Youth: An RCT Examining Feasibility, Acceptability, and Efficacy of NiteCAPP Jr

Digital Cognitive Behavioral Treatment of Insomnia in Youth: An RCT Examining Feasibility, Acceptability, and Efficacy of NiteCAPP Jr

Condition
Insomnia
Intervention / Treatment

-

Contacts and Locations

Tampa

University of South Florida, Tampa, Florida, United States, 33612

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. 6-12 yrs
  • 2. Verbal IQ \> 70 (to ensure verbal skills are sufficient to participate in treatment)
  • 3. participation of child's parent or legal guardian living in the same home
  • 4. child diagnosed with insomnia, 5) willing to accept random assignment.
  • 1. ability to read and understand English at the 5th grade level
  • 2. willing to accept random assignment.
  • 1. child unable to provide informed consent or child unable to provide assent
  • 2. child unwilling to accept random assignment
  • 3. child participation in another randomized research project
  • 4. child unable to complete forms or implement treatment procedures due to cognitive impairment
  • 5. child untreated medical comorbidity including other sleep disorders (e.g., apnea, epilepsy, psychotic disorders, suicidal ideation/intent, \[frequent\] parasomnias)
  • 6. child psychotropic or other medications that alter sleep with the exceptions of stimulants, sleep medications, and/or melatonin as described in #7 (see Notes below for details)
  • 7. child stimulants, sleep medications (prescribed or OTC), and/or melatonin within the last 1 month (unless stabilized on medication for 3+ months)
  • 8. child participation in non-pharmacological treatment (including CBT) for sleep outside current trial
  • 9. child other conditions adversely affecting trial participation.

Ages Eligible for Study

6 Years to 12 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of South Florida,

Study Record Dates

2025-12-01